Listed pharmaceutical firms to cut dividend payouts on uncertainties
Published: 2012-12-27 06:59:00
Updated: 2012-12-27 06:59:00
Korea’ listed drug firms are likely to sharply reduce their cash dividends paid out to their shareholders this year as the government’s forced price cuts for drugs and growing economic uncertainties have led them to secure capital amid a dim earnings outlook, market source said.
Given that div...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
